Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Azithromycin inhibits interleukin-6 but not fibrinogen production in hepatocytes infected with cytomegalovirus and chlamydia pneumoniae.

Bouwman JJ, Visseren FL, Bouter PK, Diepersloot RJ.

J Lab Clin Med. 2004 Jul;144(1):18-26.

PMID:
15252403
2.

Acute-phase response of human hepatocytes after infection with Chlamydia pneumoniae and cytomegalovirus.

Verkerk MS, Visseren FL, Paul Bouter K, Diepersloot RJ.

Eur J Clin Invest. 2003 Aug;33(8):720-5.

PMID:
12864783
3.

Azithromycin reduces Chlamydia pneumoniae-induced attenuation of eNOS and cGMP production by endothelial cells.

Bouwman JJ, Visseren FL, Bevers LM, van der Vlist WE, Bouter KP, Diepersloot RJ.

Eur J Clin Invest. 2005 Sep;35(9):573-82.

PMID:
16128864
4.

Infection-induced inflammatory response of adipocytes in vitro.

Bouwman JJ, Visseren FL, Bouter KP, Diepersloot RJ.

Int J Obes (Lond). 2008 Jun;32(6):892-901. doi: 10.1038/ijo.2008.36. Epub 2008 Mar 18.

PMID:
18347604
5.

Effect of levofloxacin on the viability of intracellular Chlamydia pneumoniae and modulation of proinflammatory cytokine production by human monocytes.

Baltch AL, Smith RP, Ritz WJ, Carpenter AN, Bopp LH, Michelsen PB, Carlyn CJ, Hibbs JR.

Diagn Microbiol Infect Dis. 2004 Nov;50(3):205-12.

PMID:
15541607
6.

Human cytomegalovirus increases constitutive production of interleukin-6 and leukemia inhibitory factor by bone marrow stromal cells.

Lagneaux L, Delforge A, Snoeck R, Bosmans E, Moreau JF, Taupin JL, De Clercq E, Stryckmans P, Bron D.

Blood. 1996 Jan 1;87(1):59-66.

7.

Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection model.

Kutlin A, Roblin PM, Hammerschlag MR.

J Antimicrob Chemother. 2002 May;49(5):763-7.

PMID:
12003969
8.

In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model.

Kutlin A, Roblin PM, Hammerschlag MR.

Antimicrob Agents Chemother. 1999 Sep;43(9):2268-72.

9.

Procoagulant and inflammatory response of virus-infected monocytes.

Bouwman JJ, Visseren FL, Bosch MC, Bouter KP, Diepersloot RJ.

Eur J Clin Invest. 2002 Oct;32(10):759-66.

PMID:
12406025
10.
11.

Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment.

Gieffers J, F├╝llgraf H, Jahn J, Klinger M, Dalhoff K, Katus HA, Solbach W, Maass M.

Circulation. 2001 Jan 23;103(3):351-6.

12.

Interleukin-6 production by endothelial cells after infection with influenza virus and cytomegalovirus.

Visseren FL, Verkerk MS, Bouter KP, Diepersloot RJ, Erkelens DW.

J Lab Clin Med. 1999 Dec;134(6):623-30.

PMID:
10595791
13.

Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model.

Muhlestein JB, Anderson JL, Hammond EH, Zhao L, Trehan S, Schwobe EP, Carlquist JF.

Circulation. 1998 Feb 24;97(7):633-6.

14.

Acute Chlamydia pneumoniae reinfection accelerates the development of insulin resistance and diabetes in obese C57BL/6 mice.

Wang C, Gao D, Kaltenboeck B.

J Infect Dis. 2009 Jul 15;200(2):279-87. doi: 10.1086/599796.

PMID:
19508161
15.

Effect of macrolide antibiotics on human endothelial cells activated by Chlamydia pneumoniae infection and tumor necrosis factor-alpha.

Uriarte SM, Molestina RE, Miller RD, Bernabo J, Farinati A, Eiguchi K, Ramirez JA, Summersgill JT.

J Infect Dis. 2002 Jun 1;185(11):1631-6. Epub 2002 May 17.

PMID:
12023769
16.

Chlamydia pneumoniae induces interleukin-6 and interleukin-10 in human gingival fibroblasts.

Rizzo A, Paolillo R, Lanza AG, Guida L, Annunziata M, Carratelli CR.

Microbiol Immunol. 2008 Sep;52(9):447-54.

PMID:
19039953
17.
18.

Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.

Rothstein NM, Quinn TC, Madico G, Gaydos CA, Lowenstein CJ.

J Infect Dis. 2001 Jan 15;183(2):232-238. Epub 2000 Dec 13.

PMID:
11120929
19.

In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae.

Gnarpe J, Eriksson K, Gnarpe H.

Antimicrob Agents Chemother. 1996 Aug;40(8):1843-5.

20.

IL-1 and IL-6 induce hepatocyte plasminogen activator inhibitor-1 expression through independent signaling pathways converging on C/EBPdelta.

Dong J, Fujii S, Imagawa S, Matsumoto S, Matsushita M, Todo S, Tsutsui H, Sobel BE.

Am J Physiol Cell Physiol. 2007 Jan;292(1):C209-15. Epub 2006 Aug 16.

Supplemental Content

Support Center